Shimon Eckhouse

Co-founder and Chairman of the Board

2017 - Current

Co-Founder and Chairman of the board

2016

Co founder and Chairman

2015

Co-Founder and Chairman of the Board

2005

Epitomee medical is a private company developing and commercializing drug-free self-administered, shapeshifting capsules, aimed to prevent diabetes and address overweight & obesity co-morbidities by promoting weight loss and establishing a healthier lifestyle

Co-Founder and Chairman Of The Board

2008

Co founder and chairman

2008

Co founder and chairman

2017

Founder, owner and Chairman

2014

Founder, owner and Chairman of Alon Medtech incubator in Israel which is investing in early stage start-ups in health care technologies and is part of the Israeli Innovation Authority incubator program. Alon’s current portfolio consists of 15 medical technology companies in fields such as cardiology, digital and personalized medicine, aesthetic medicine and minimally invasive surgery.

Co-founder and Chairman

2001

Co-founder and Chairman of Tulip Ltd., Rapid Medical Ltd., Opticul Diagnostic Ltd., C3D Ltd., RealView Ltd. , Theranica Ltd and the Chairman of Orsense Ltd. ColorChip Ltd., Ventor Medical Technologies Ltd. (acquired by Medtronic in 2009). Co-founder of Monterey Bay Labs Inc. (Nanocyte).

Co founder and chairman of the board

2000 - 2017

Co-founder and Chairman

2000 - 2017

Until recently Active Chairman of Syneron-Candela Ltd. (Nasdaq ELOS) which he co-founded in September 2000 and took public on Nasdaq in 2004 returning to its investors X80 on their original investment. Syneron-Candela is a global leader in aesthetic medical devices with 2016 revenue of approximately $300M in 2016. On July 2017 Syneron-Candela was acquired by APAX partners in a “going private” transaction.

Founder, chairman and CEO

1992 - 1999

Founder, chairman and CEO of ESC Medical Systems (now Lumenis). The success of ESC (Lumenis) was based on the invention of IPL (Intense Pulsed Light( in 1992. Using this technology the company became the first global leader in medical and aesthetic lasers. Took the company public on Nasdaq in January of 1996 and raised more than $250M in 3 public offerings, the company reached a valuation of more than $1B returning to its investors more than X120 on their investment in the company.

Head of product development and technical director

1986 - 1991